Valley Brook Capital Group, Inc. Amgen Inc Transaction History
Valley Brook Capital Group, Inc.
- $127 Million
- Q1 2024
A detailed history of Valley Brook Capital Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Valley Brook Capital Group, Inc. holds 4,865 shares of AMGN stock, worth $1.52 Million. This represents 1.09% of its overall portfolio holdings.
Number of Shares
4,865
Previous 4,730
2.85%
Holding current value
$1.52 Million
Previous $1.36 Million
1.54%
% of portfolio
1.09%
Previous 1.16%
Shares
13 transactions
Others Institutions Holding AMGN
# of Institutions
2,930Shares Held
401MCall Options Held
6.59MPut Options Held
6.6M-
Vanguard Group Inc Valley Forge, PA52.1MShares$16.3 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY48MShares$15 Billion0.32% of portfolio
-
State Street Corp Boston, MA29.1MShares$9.1 Billion0.38% of portfolio
-
Primecap Management CO Pasadena, CA14.6MShares$4.56 Billion3.15% of portfolio
-
Morgan Stanley New York, NY14MShares$4.37 Billion0.32% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $167B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...